Breast Cancer Clinical Trials

Clinical Trial: MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Clinical Trial: Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer

Clinical Trial: Circadian Disturbances After Breast Cancer Surgery (CIRCA)

Clinical Trial: Genomic Testing for Primary Breast Cancer

Clinical Trial: Breast Cancer Prevention Education

Clinical Trial: Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors

Clinical Trial: A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)

Clinical Trial: Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

Clinical Trial: Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC)

Clinical Trial: Statins and Breast Cancer Biomarkers

Clinical Trial: Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Clinical Trial: Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

Clinical Trial: Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC)

For a complete listing of clinical trials pertaining to Breast Cancer via ClinicalTrials.gov, click here.

Breast Cancer News

In HER2 breast cancer, lapatinib works better with trastuzumab than without

Education Reduces Distress During Breast Cancer Treatment

Parabens found in breast tumor tissue of nonusers of underarm products

Not Enough Americans Being Screened for Cancer

Radiation Benefits Mixed After Breast-Preserving Surgery

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey


Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions